Skip to main content

Want a detailed portfolio tracker?

Sol-Gel Technologies (SLGL) Revenue (2015 - 2025)

Sol-Gel Technologies (SLGL) revenue from Dec 31, 2015 to Dec 31, 2025. The TTM Sol-Gel Technologies (SLGL) revenue is $3.80M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Revenue

Sol-Gel Technologies (SLGL) Revenue CAGR table

PeriodCAGR
1 Year-
5 Years-15.21%

Annual Revenue change of Sol-Gel Technologies (SLGL)

YearRevenueChange
2025$3.80MN/A
2024$3.80M+145.16%
2023$1.55MN/A
2022$0-100.00%
2021$3.30M-61.94%
2020$8.67M-61.97%
2019$23M+17438.46%
2018$130K-23.53%
2017$170KN/A
2016$0N/A
2015$0N/A

Comparison Sol-Gel Technologies (SLGL) five years revenue CAGR with competitors

Sol-Gel Technologies (SLGL) five years revenue CAGR is -15.21%.

TickerNamefive years Revenue CAGRUpside
BEAMBeam Therapeutics Inc484.70%-3285.82%
RYTMRhythm Pharmaceuticals Inc473.51%-3212.31%
CRMDCorMedix Inc336.16%-2309.53%
TGTXTG Therapeutics Inc278.04%-1927.52%
GERNGeron Corp257.04%-1789.48%
RVNCRevance Therapeutics Inc216.35%-1522.02%
FENCFennec Pharmaceuticals Inc202.90%-1433.65%
IBRXImmunityBio Inc200.12%-1415.34%
ASNDAscendis Pharma A/S175.66%-1254.57%
VXRTVaxart Inc174.17%-1244.78%
AAPGAscentage Pharma Group International171.81%-1229.26%
SNDXSyndax Pharmaceuticals Inc169.88%-1216.56%
OCGNOcugen Inc153.09%-1106.21%
BBIOBridgeBio Pharma Inc131.56%-964.72%
PRTAProthena Corporation plc131.47%-964.12%
CTXRCitius Pharmaceuticals Inc128.54%-944.88%
TLXTelix Pharmaceuticals Ltd123.87%-914.17%
PRQRProQR Therapeutics N.V121.71%-899.94%
BOLTBolt Biotherapeutics Inc121.10%-895.96%
PLURPluri Inc115.90%-861.81%
RPTXRepare Therapeutics Inc114.08%-849.84%
ATHEAlterity Therapeutics Ltd111.91%-835.54%
VRDNViridian Therapeutics Inc111.57%-833.32%
MRSNMersana Therapeutics Inc109.71%-821.12%
FHTXFoghorn Therapeutics Inc108.52%-813.26%
ARDXArdelyx Inc101.30%-765.80%
ARGXArgen X SE96.87%-736.68%
SEERSeer Inc - Class A94.78%-722.94%
ABUSArbutus Biopharma Corp90.98%-697.97%
GYREGyre Therapeutics Inc80.86%-631.46%
ENSCEnsysce Biosciences Inc79.79%-624.47%
TARSTarsus Pharmaceuticals Inc74.12%-587.18%
LEGNLegend Biotech Corp70.27%-561.90%
TRAWTraws Pharma Inc64.59%-524.52%
ADAGAdagene Inc61.38%-503.41%
CVACCureVac N.V.60.56%-498.02%
ADMAAdma Biologics Inc60.37%-496.79%
RXRXRecursion Pharmaceuticals Inc - Class A59.35%-490.07%
CGENCompugen Ltd57.53%-478.15%
ADAPAdaptimmune Therapeutics plc American Depositary Shares55.42%-464.26%
LCTXLineage Cell Therapeutics Inc54.06%-455.32%
CUECue Biopharma Inc53.77%-453.41%
MRKRMarker Therapeutics Inc53.28%-450.18%
IDYAIdeaya Biosciences Inc53.10%-448.99%
ALNYAlnylam Pharmaceuticals Inc49.77%-427.12%
FDMT4D Molecular Therapeutics Inc49.16%-423.11%
ZLABZai Lab Ltd49.02%-422.18%
URGNUroGen Pharma Ltd48.76%-420.50%
ARWRArrowhead Pharmaceuticals Inc47.49%-412.14%
ONCBeiGene Ltd46.08%-402.89%
ARCTArcturus Therapeutics Holdings Inc43.41%-385.31%
AUPHAurinia Pharmaceuticals Inc42.37%-378.47%
BCYCBicycle Therapeutics Plc41.82%-374.85%
XBIOXenetic Biosciences Inc41.05%-369.81%
MNKDMannkind Corp40.31%-364.95%
ZVRAZevra Therapeutics Inc39.30%-358.30%
BRTXBioRestorative Therapies Inc38.99%-356.26%
IMRNImmuron Ltd38.57%-353.53%
MGTXMeiraGTx Holdings plc37.98%-349.63%
CPRXCatalyst Pharmaceuticals Inc37.80%-348.45%
HRMYHarmony Biosciences Holdings Inc37.73%-347.99%
INSMInsmed Inc37.33%-345.38%
HALOHalozyme Therapeutics Inc35.42%-332.79%
WVEWave Life Sciences Ltd35.16%-331.11%
APLSApellis Pharmaceuticals Inc34.55%-327.09%
ARVNArvinas Inc33.48%-320.05%
EVGNEvogene Ltd32.81%-315.64%
NBTXNanobiotix31.49%-306.99%
CRSPCRISPR Therapeutics AG30.10%-297.81%
NRIXNurix Therapeutics Inc29.16%-291.68%
SRPTSarepta Therapeutics Inc26.94%-277.08%
ANABAnaptysBio Inc26.67%-275.33%
VRCAVerrica Pharmaceuticals Inc25.37%-266.73%
LXRXLexicon Pharmaceuticals Inc24.38%-260.24%
NTRBNutriband Inc23.29%-253.08%
TVTXTravere Therapeutics Inc22.05%-244.95%
RANIRani Therapeutics Holdings Inc Class A21.08%-238.52%
FOLDAmicus Therapeutics Inc19.44%-227.79%
GLPGGalapagos NV19.11%-225.58%
ACADAcadia Pharmaceuticals Inc19.04%-225.13%
DYAIDyadic International Inc DE19.03%-225.05%
OCULOcular Therapeutix Inc18.64%-222.54%
EXELExelixis Inc18.17%-219.43%
VCELVericel Corp17.77%-216.81%
CORTCorcept Therapeutics Inc17.73%-216.53%
TNGXTango Therapeutics Inc17.63%-215.90%
RIGLRigel Pharmaceuticals17.49%-214.98%
NAGENiagen Bioscience Inc16.96%-211.45%
PTGXProtagonist Therapeutics Inc16.30%-207.11%
RAREUltragenyx Pharmaceutical Inc14.93%-198.14%
INCYIncyte Corp14.68%-196.48%
STROSutro Biopharma Inc14.67%-196.45%
MRUSMerus N.V14.54%-195.54%
PTCTPTC Therapeutics Inc13.95%-191.71%
VRTXVertex Pharmaceuticals Inc13.75%-190.39%
CELUCelularity Inc - Class A13.21%-186.82%
JAZZJazz Pharmaceuticals plc12.75%-183.78%
HRTXHeron Therapeutics Inc12.60%-182.83%
CYTKCytokinetics Inc12.56%-182.59%
BMRNBiomarin Pharmaceutical Inc11.94%-178.50%
OPTOpthea Ltd11.41%-175.00%
SPROSpero Therapeutics Inc11.22%-173.74%
PHARPharming Group N.V.10.70%-170.34%
TBPHTheravance Biopharma Inc10.63%-169.85%
ABVCABVC BioPharma Inc10.50%-169.04%
REGNRegeneron Pharmaceuticals Inc10.16%-166.77%
HCWBHCW Biologics Inc9.96%-165.50%
DAREDare Bioscience Inc9.62%-163.25%
MDXGMimedx Group Inc9.58%-162.97%
VALNValneva SE9.35%-161.44%
CSBRChampions Oncology Inc9.14%-160.05%
IONSIonis Pharmaceuticals Inc8.38%-155.11%
CYCNCyclerion Therapeutics Inc8.20%-153.89%
LGNDLigand Pharmaceuticals Inc - Class B8.15%-153.54%
FBIOFortress Biotech Inc8.13%-153.46%
SVASinovac Biotech Ltd7.99%-152.52%
AGENAgenus Inc7.88%-151.81%
ABEOAbeona Therapeutics Inc7.77%-151.09%
MGNXMacrogenics Inc7.76%-151.03%
PLXProtalix BioTherapeutics Inc7.76%-150.99%
TECHBio-Techne Corp7.39%-148.55%
CRDFCardiff Oncology Inc7.25%-147.64%
JAGXJaguar Health Inc7.22%-147.48%
CLLSCellectis6.98%-145.88%
CASICASI Pharmaceuticals Inc6.66%-143.81%
IGCIGC Pharma Inc6.63%-143.56%
ACIUAC Immune SA6.29%-141.31%
DTILPrecision Biosciences Inc6.03%-139.62%
CRBPCorbus Pharmaceuticals Holdings Inc5.98%-139.33%
KPTIKaryopharm Therapeutics Inc5.95%-139.09%
NTLAIntellia Therapeutics Inc5.11%-133.56%
IVAInventiva4.71%-130.94%
DNAGinkgo Bioworks Holdings Inc - Class A4.63%-130.41%
INVAInnoviva Inc4.13%-127.14%
ACRSAclaris Therapeutics Inc4.08%-126.79%
VTGNVistaGen Therapeutics Inc4.06%-126.65%
IMMPImmutep Ltd3.96%-126.02%
PGENPrecigen Inc3.45%-122.68%
IMTXImmatics N.V3.26%-121.45%
XNCRXencor Inc2.91%-119.12%
RPRXRoyalty Pharma plc - Class A2.82%-118.57%
ICCCImmucell Corp2.75%-118.07%
BNTXBioNTech SE2.17%-114.25%
LSTALisata Therapeutics Inc1.86%-112.26%
CDXSCodexis Inc1.52%-109.99%
HYFTMindWalk Holdings Corp1.38%-109.09%
KYMRKymera Therapeutics Inc0.86%-105.68%
ALECAlector Inc0.42%-102.75%